Interest in 670nm red light for eyes has grown rapidly in recent years, especially as researchers investigate how deep red light may interact with the retina, mitochondrial function, and age-related changes in vision.

Unlike ordinary visible lighting, 670nm light belongs to the long-wavelength red portion of the visible spectrum. Researchers have been studying whether exposure to specific wavelengths of red light may influence biological processes inside retinal cells.

One of the most widely discussed areas of research comes from scientists at University College London (UCL), who investigated whether short exposures to 670nm deep red light could affect visual function in aging adults.

The results were intriguing—but they also need to be understood in the context of the study design and its limitations.

So, what does the research actually show about 670nm red light for eyes?

Let's take a closer look.

---

What Is 670nm Red Light?

The term 670nm refers to the wavelength of light.

"nm" means nanometer, a unit used to measure wavelength.

Visible light occupies approximately the 380–700nm range, although the exact boundaries vary depending on how the spectrum is defined.

670nm light is therefore located toward the deep-red end of visible light.

It is important to distinguish wavelength from other properties of light.

For example:

• 670nm = optical wavelength

• 40Hz = temporal modulation frequency

• mW/cm² = irradiance

• J/cm² = energy delivered per unit area

These measurements describe different characteristics of a light source.

When discussing 670nm red light for eyes, wavelength is particularly important because researchers are investigating how specific wavelengths interact with biological tissues and cellular processes.

---

Why Are Scientists Studying Red Light for the Eyes?

The retina is one of the most metabolically active tissues in the human body.

Photoreceptor cells require substantial amounts of energy to maintain normal function. This energy is produced largely by mitochondria.

Mitochondria are often described as the energy-producing structures of cells because they generate ATP, the primary energy currency used by cells.

As people age, mitochondrial function can change.

Researchers have therefore asked whether certain wavelengths of red or near-infrared light could interact with mitochondria and potentially influence cellular energy processes.

This research area is commonly referred to as photobiomodulation, or PBM.

Reviews of ocular photobiomodulation describe mitochondrial activity, oxidative stress, inflammation, and cellular signaling as important areas of investigation.

---

How Might 670nm Light Interact With Retinal Cells?

One proposed mechanism involves mitochondrial components such as cytochrome c oxidase, an enzyme complex involved in cellular respiration.

Laboratory and experimental research suggests that red and near-infrared wavelengths may interact with mitochondrial photoacceptors and influence cellular energy-related processes.

Studies have reported effects involving mitochondrial respiration, ATP production, oxidative stress, and cellular signaling.

This provides a biological rationale for investigating red light in the retina.

However, there is an important distinction:

A plausible biological mechanism does not by itself prove a clinical benefit.

Researchers still need human studies to determine whether changes at the cellular level translate into meaningful improvements in visual function.

---

What Does 670nm Light Have to Do With Vision?

The retina contains specialized photoreceptors called rods and cones.

Rods

Rods are particularly important for vision in dim or low-light conditions and peripheral vision.

Cones

Cones are responsible for color vision and detailed vision under brighter lighting conditions.

Because these cells have high metabolic demands, researchers have investigated whether age-related mitochondrial changes could contribute to declining retinal function.

This is one reason 670nm deep red light has become an interesting subject in vision research.

---

The UCL 670nm Research

One of the most widely cited human studies was conducted by researchers at University College London Institute of Ophthalmology.

In a 2020 study, researchers investigated whether 670nm deep red light could influence visual function in adults of different ages.

The study included 24 participants between 28 and 72 years old who did not have ocular disease.

Participants were given a small LED device and asked to look into its 670nm deep red light for three minutes per day for two weeks.

Researchers then assessed rod and cone sensitivity.

The results suggested that the effect was more apparent in older participants, particularly those around 40 years of age and older.

The researchers proposed that the findings could be related to age-associated changes in mitochondrial function.

This was an important early human investigation because it moved the research beyond laboratory models and into human visual testing.

---

The 2021 UCL Study: Why Timing May Matter

A subsequent UCL study explored an even shorter exposure.

Researchers investigated whether a single three-minute exposure to 670nm deep red light could influence color contrast vision.

Twenty adults between 34 and 70 years old participated in the morning exposure experiment.

Participants received three minutes of 670nm light between approximately 8 a.m. and 9 a.m.

The researchers then tested color contrast vision.

On average, they reported approximately a 17% improvement in color contrast vision, with the effect observed for at least one week in the subset of participants who were tested again after one week.

Importantly, the same improvement was not observed when the exposure was performed in the afternoon.

This led researchers to propose that the timing of light exposure may be relevant to retinal mitochondrial function.

---

Why Would Morning Exposure Matter?

The timing finding is particularly interesting.

Mitochondria do not necessarily operate at exactly the same level throughout the day. Cellular metabolism and energy requirements can change with biological rhythms.

The UCL researchers therefore investigated whether retinal response to deep red light might depend on the time of day.

Their 2021 study found a measurable response following morning exposure but not afternoon exposure.

This does not mean that everyone should automatically use 670nm light only in the morning.

Instead, it shows that timing is an important variable worth studying.

Light-based interventions can depend on many parameters, including:

• wavelength

• intensity

• exposure duration

• time of day

• distance

• delivery method

• frequency of use

• individual characteristics

Future research will help determine how these factors interact.

---

Does 670nm Red Light Improve Eyesight?

This is one of the most common questions.

The answer requires some precision.

Human studies have reported improvements in specific measures of visual function following 670nm exposure.

For example, the UCL research investigated color contrast sensitivity, rather than simply asking participants whether they could see better.

That distinction matters.

"Eyesight" is a broad term.

It can refer to:

• visual acuity

• color vision

• contrast sensitivity

• low-light vision

• peripheral vision

• retinal sensitivity

• other aspects of visual performance

An improvement in one measure does not necessarily mean that all aspects of eyesight improve.

Therefore, it is more scientifically accurate to say that some human studies have reported improvements in specific measures of visual function following 670nm exposure.

That is different from saying that 670nm red light has been proven to improve eyesight in everyone.

---

What Is Color Contrast Sensitivity?

Color contrast sensitivity measures how well someone can distinguish subtle differences between colors.

In the UCL research, participants were asked to identify colored letters that had very low contrast and became increasingly difficult to distinguish.

This provides a quantitative way to evaluate certain aspects of visual function.

The 2021 study focused particularly on cone-mediated color contrast.

The researchers reported an average improvement of approximately 17% following a single morning exposure in their study group.

This is one of the reasons the study attracted attention.

However, color contrast sensitivity is only one component of vision.

---

What Does Research Say About the Retina?

The retina is particularly interesting for photobiomodulation research because it contains a high density of mitochondria and has substantial energy requirements.

Experimental studies have investigated whether red and near-infrared light can influence retinal mitochondrial activity and protect retinal cells under certain stress conditions.

For example, laboratory research involving 670nm light has reported changes in mitochondrial metabolism and cellular responses in retinal models.

Other research has investigated red and near-infrared photobiomodulation in models of retinal damage and neurodegeneration.

These findings provide biological evidence supporting continued investigation.

But laboratory and animal research should not be interpreted as proof of the same effect in humans.

---

670nm Red Light and Mitochondria

The connection between 670nm light and mitochondria is one of the most important scientific concepts behind this field.

Mitochondria generate ATP through oxidative phosphorylation.

The retina has a very high energy demand, particularly because photoreceptors continuously perform processes required for visual signaling.

Research has suggested that aging can be associated with changes in mitochondrial efficiency.

Scientists therefore investigate whether long-wavelength red light can influence mitochondrial processes.

A 2016 experimental study reported that 670nm light increased the redox state of mitochondria in retinal tissue.

Earlier work from the same research group also investigated how long-wavelength light could affect mitochondrial function in aging eyes.

These findings help explain why 670nm has become an important wavelength in retinal photobiomodulation research.

---

Is 670nm the Only Wavelength Studied for Eye Health?

No.

Researchers have investigated a range of red and near-infrared wavelengths.

Reviews of ocular photobiomodulation commonly discuss wavelengths spanning portions of the red and near-infrared spectrum, including approximately 630–800nm and beyond depending on the application.

Different wavelengths may behave differently in biological tissues.

Therefore:

Evidence for one wavelength should not automatically be transferred to another wavelength.

This is particularly important when comparing:

• 630nm

• 650nm

• 660nm

• 670nm

• 810nm

• 830nm

• 850nm

They are not simply interchangeable.

---

Why Is 670nm Particularly Interesting?

670nm has attracted attention because of several lines of research.

First, it falls within the long-wavelength red-light region being investigated for photobiomodulation.

Second, experimental research has linked 670nm exposure with mitochondrial activity in retinal tissue.

Third, human research from UCL has investigated 670nm exposure and visual function in aging adults.

Together, these findings provide a logical research pathway:

670nm light → retinal light exposure → cellular/mitochondrial response → possible changes in retinal function → measurable visual outcomes

But each step still needs to be studied carefully.

The existence of a proposed pathway does not mean every step has been definitively established for every person or every device.

---

What About Age-Related Vision Changes?

Age is an important factor in this field.

The UCL studies specifically investigated age-related changes in visual function and found stronger responses in older participants than in younger participants.

Other research has also investigated 670nm photobiomodulation in people with age-related retinal changes, including studies involving age-related macular degeneration.

For example, a pilot study investigated 670nm photobiomodulation in people with intermediate AMD as well as older adults with normal retinas.

These studies are part of a broader research field exploring whether mitochondrial and cellular processes can be influenced by targeted light exposure.

However, the evidence varies considerably depending on the condition, study design, and treatment protocol.

---

What About Age-Related Macular Degeneration?

Age-related macular degeneration, or AMD, is another important area of photobiomodulation research.

Researchers have investigated whether red and near-infrared light could influence retinal function and biological processes associated with retinal aging.

Some small clinical studies have reported encouraging findings.

For example, a pilot study examined 670nm exposure in people with intermediate AMD and assessed visual and structural outcomes over time.

Other studies have investigated 670nm LED photobiomodulation in people with dry AMD.

However, these studies should not be interpreted as proof that consumer 670nm products treat or cure AMD.

AMD is a complex medical condition that requires appropriate ophthalmic diagnosis and management.

---

Is 670nm Red Light the Same as Near-Infrared Light?

No.

This distinction is especially important.

670nm is visible deep red light.

Near-infrared light generally refers to longer wavelengths beyond the visible red spectrum.

Both red and near-infrared light are being investigated for photobiomodulation, but their optical properties and tissue interactions can differ.

Therefore, research on 810nm or 850nm near-infrared light should not automatically be presented as evidence for 670nm light.

This is one reason wavelength-specific research is important.

---

What Does Current Research Actually Support?

The evidence can be organized into several levels.

Stronger evidence

Human research demonstrates that appropriately delivered 670nm light can produce measurable changes in certain aspects of visual function under specific experimental conditions.

Promising evidence

Research suggests that red-light photobiomodulation may interact with mitochondrial and cellular processes relevant to retinal function.

Early or exploratory evidence

Researchers are investigating potential applications involving:

• age-related visual changes

• retinal aging

• AMD

• retinal stress

• mitochondrial dysfunction

• other ocular conditions

Not yet established

Current evidence does not justify saying that 670nm red light:

• cures eye disease

• reverses blindness

• permanently restores vision

• treats every form of poor eyesight

• replaces an eye examination

• replaces prescribed ophthalmic treatment

The scientific field is promising, but it is still developing.

---

Why Do Different Studies Produce Different Results?

One reason is that "red light therapy" is not a single standardized treatment.

Studies may use different:

• wavelengths

• irradiance levels

• energy doses

• exposure durations

• treatment schedules

• distances

• light sources

• delivery systems

• participant ages

• eye conditions

• outcome measurements

A 670nm study using a specific exposure protocol cannot automatically validate a completely different device.

Recent reviews emphasize that photobiomodulation outcomes are strongly dependent on device parameters, dosimetry, wavelength, treatment protocols, and study design.

This is particularly important when comparing research devices with consumer products.

---

670nm Red Light Glasses and Research Devices

Wearable 670nm glasses can make red-light exposure more convenient.

However, consumers should not assume that every pair of 670nm glasses reproduces the exact conditions used in published research.

Research protocols may specify:

• exact wavelength

• irradiance

• exposure duration

• distance from the eye

• optical geometry

• field of illumination

• treatment frequency

• timing of exposure

Even two products that both advertise "670nm" may deliver different amounts of light to the eye.

Therefore, wavelength is important, but it is not the only specification that matters.

---

How Much 670nm Light Is Needed?

There is currently no single universally established exposure protocol for all purposes.

Different studies have used different protocols.

For example, the UCL studies investigated very short exposure periods, including three-minute protocols.

Other photobiomodulation studies have used different energy densities and treatment schedules.

This means consumers should not assume:

"If three minutes worked in one study, more time must work better."

Photobiomodulation is often described as having parameter-dependent biological responses, and more light is not necessarily better.

The appropriate exposure depends on the specific device and protocol.

---

Does 670nm Red Light Work Better in the Morning?

The UCL 2021 study provides an interesting reason to pay attention to timing.

The researchers observed an improvement following morning exposure but did not observe the same improvement in the afternoon condition.

This suggests that the time of day may influence the response.

However, this was a specific experimental finding, not a universal rule established for all 670nm devices and all users.

More research is needed to determine how timing interacts with:

• age

• retinal condition

• light intensity

• exposure duration

• circadian biology

• individual mitochondrial function

This topic deserves further investigation.

---

Is 670nm Red Light Safe for Eyes?

Safety is an important consideration whenever light is directed toward the eyes.

Red and near-infrared photobiomodulation are being actively investigated in ophthalmology, and clinical studies have generally explored relatively low-energy exposure protocols.

However, safety depends on the actual optical parameters of the device.

Important factors include:

• wavelength

• irradiance

• exposure duration

• energy dose

• optical design

• distance

• eye condition

A wavelength alone cannot determine whether a particular device is safe.

People with existing eye diseases, photosensitivity, recent eye surgery, or other eye-related concerns should consult an appropriate eye-care professional before using light-based devices directed toward the eyes.

And importantly, never stare into an unspecified high-power light source simply because it is described as "red light."

---

What Are Researchers Studying Next?

Research into 670nm and ocular photobiomodulation continues to expand.

Current areas of interest include:

Retinal aging

Researchers are studying how mitochondrial changes may relate to declining retinal function.

Macular health

Studies are investigating whether photobiomodulation may influence retinal structure and function in age-related conditions.

Mitochondrial function

Researchers continue to investigate how different wavelengths interact with mitochondrial processes.

Personalized protocols

Different people may respond differently to the same wavelength and dose.

Long-term safety

Longer studies are needed to better understand sustained exposure and long-term outcomes.

Home-based technology

Researchers are also interested in whether appropriately designed light-based devices could make certain interventions more accessible.

---

Frequently Asked Questions

What is 670nm red light?

670nm is a specific wavelength of visible deep red light. It has been studied in relation to retinal mitochondrial function and visual performance.

Can 670nm red light improve eyesight?

Some human studies have reported improvements in specific measures of visual function, particularly color contrast sensitivity. However, this does not mean that 670nm improves every aspect of eyesight or treats eye disease.

Why is 670nm used for eye research?

Research suggests that long-wavelength red light can interact with biological processes involving retinal mitochondria. Human studies have also reported measurable visual responses to 670nm exposure.

What did the UCL study find?

A UCL study reported that a single three-minute morning exposure to 670nm light was associated with an average 17% improvement in color contrast vision in its study participants, with the effect observed for at least a week in a subset tested later. The afternoon condition did not show the same improvement.

Is 670nm the same as 660nm?

No. Both are red-light wavelengths, but they are different wavelengths. Research conducted at one wavelength should not automatically be treated as evidence for another.

Is 670nm red light the same as 850nm near-infrared light?

No. 670nm is visible deep red light, while 850nm is near-infrared. They have different optical properties and should be considered separately when interpreting research.

Can 670nm red light treat AMD?

Research into 670nm photobiomodulation and AMD is ongoing. Some pilot studies have reported promising findings, but 670nm consumer products should not be presented as established treatments for AMD.

Why does the UCL research emphasize morning exposure?

The researchers found different results between morning and afternoon exposure in one study. This suggests timing may matter, although more research is needed before universal recommendations can be made.

Can I use 670nm red light instead of seeing an eye doctor?

No. Red-light research does not replace professional eye examinations or medical treatment when an eye condition is suspected.

---

The Bottom Line

So, what does the research actually show about 670nm red light for eyes?

The evidence is scientifically interesting and increasingly substantial, but it needs to be interpreted carefully.

Human research has shown that specific 670nm exposure protocols can influence measurable aspects of visual function. UCL research has reported improvements in color contrast sensitivity following short morning exposures, particularly in older adults. Other laboratory and clinical research suggests that red-light photobiomodulation may interact with mitochondrial and cellular processes in the retina.

At the same time, research remains heterogeneous, and the effects depend on wavelength, dose, timing, exposure duration, device design, and the characteristics of the people being studied.

The most responsible conclusion is therefore:

670nm red light is a promising area of research for retinal and visual health, with encouraging human evidence for certain measures of visual function—but it should not yet be treated as a universal treatment for eye disease or vision loss.

As research continues, larger studies and standardized protocols will help clarify exactly when, how, and for whom 670nm light may be most useful.

Related Topics

If you are interested in the science of 670nm red light and eye health, future articles in this series will explore:

• How 670nm red light may work

• 670nm and retinal mitochondria

• 670nm and age-related vision

• 670nm and macular health

• 670nm and AMD research

• 670nm for eye strain

• 3-minute 670nm exposure

• Morning vs. afternoon exposure

• 670nm vs. 660nm

• 670nm vs. near-infrared light

• 670nm eye safety

• How to use 670nm red light for eyes